SQ-LIP-000015 · v1.9 (archived) · View current version →
What is the recommended overall management of lipedema?
Also asked as
- How should lipedema be managed overall?
- What is the recommended treatment approach for someone with lipedema?
- Best practices for managing lipedema
- Which combined therapies and strategies make up the standard care plan for lipedema?
Lipedema is managed with an individualized, multidisciplinary plan that starts with conservative care (compression, exercise, weight/diet, psychosocial support) to relieve pain and swelling, with liposuction added for selected patients who improves pain, mobility and quality of life. No treatment cures the disease, high-quality randomized comparative trials are lacking, and guidelines still disagree on the role of liposuction and manual lymphatic drainage.
- Current answer
- The recommended overall management of lipedema is an individualized, stepwise, multidisciplinary approach (potentially involving vascular surgery, endocrinology, orthopedics…
- Knowledge state
- Probable · Evidence confidence: very low–low (GRADE) · Stability: Stabilizing
- Evidence
- 19 consistent · 0 conflicting · 8 refining / contextual
- ⚠ none indexed yet — the registry may under-detect disconfirming evidence (a known limitation)
- Evidence verification
- 36/36 sources independently verified
- Main limitation
- Whether any treatment modifies the disease course (rather than only relieving symptoms) remains undemonstrated, and the surgical evidence base still lacks randomized controlled…
- Latest change
- This update added a moderate-grade single-arm meta-analysis (6 studies, 429 patients) reinforcing tumescent liposuction's pain reduction, a cohort identifying… · v1.9
- Knowledge freshness
- 81% recent · current evidence base
- Last updated
- 2026-07-26 · v1.9
| Pain (conservative therapy) | reduced | moderate (GRADE) | symptom-only |
| Compression, diet, aquatic exercise reduce pain (Grade 2A-2B); symptomatic only. | |||
| Swelling/edema (conservative) | reduced | moderate (GRADE) | symptom-only |
| CDT/compression reduce swelling; volume reduction modest (~5-10%). | |||
| Pain (liposuction) | reduced | moderate (GRADE) | symptom-only |
| Meta-analyses show large pain reduction; no RCT comparative data. | |||
| Quality of life (liposuction) | improved | moderate (GRADE) | symptom-only |
| Large QoL improvement (SMD 2.48); mostly uncontrolled before-after data. | |||
| Mobility (liposuction) | improved | low (GRADE) | symptom-only |
| Improved mobility reported; LIPLEG RCT showed early benefit at 6 months. | |||
| Disease modification / cure | not demonstrated | very_low (GRADE) | symptom-only |
| No modality shown to alter disease course; ~51% still need conservative care. | |||
| Weight loss (VLCKD diet) | improved | very_low (GRADE) | symptom-only |
| Preliminary signals; pain benefit transient, returns after diet cessation. | |||
| Surgical complications/safety | mixed | low (GRADE) | symptom-only |
| Low serious rates (seroma <1%, zero mortality) but fibrosis 28%, loose skin 75%. | |||
| Reduced reliance on conservative therapy | reduced | low (GRADE) | symptom-only |
| Post-liposuction CDT score ~37.5% lower, ~25.5% discontinued; retrospective data. | |||
Based on currently indexed evidence, the recommended overall management of lipedema is an individualized, stepwise, multidisciplinary approach (potentially involving vascular surgery, endocrinology, orthopedics, plastic surgery, physiotherapy, nutrition, gynecology, and psychiatry/psychology) addressing both physical and mental health, with early recognition, specialized care, and structured follow-up. First-line treatment is CONSERVATIVE, and surgery is generally considered only after roughly 12 months of clinical treatment, prioritizing mobility and symptom relief over aesthetics. Multiple systematic reviews and national/expert guidelines converge on optimizing conservative measures: compression therapy (flat-knit garments, generally indicated when edema is present; intermittent pneumatic compression for pain relief), structured/low-impact and aquatic exercise, weight and edema management, and anti-inflammatory/hypocaloric or ketogenic dietary approaches; combined compression plus exercise outperforms exercise alone. OUTCOME-SPECIFIC: conservative therapies (diet, compression, aquatic exercise) reduce PAIN and SWELLING (Grade 2A-2B) but produce only modest volume reduction (complex decongestive therapy ~5-10%, up to ~10% leg-circumference reduction); these are SYMPTOMATIC, not curative. One small uncontrolled case series (n=22) found CDT plus pneumatic compression reduced extracellular and intracellular fluid (a hypothesized—NOT demonstrated—mechanism for slowing progression). Liposuction (predominantly tumescent; also water-assisted/power-assisted, including lymph-sparing multistage approaches) is the surgical method of choice and is reserved for selected patients when conservative treatment fails or symptoms persist (commonly >=12 months), with patient-selection criteria favoring lower BMI (often <35 kg/m2), stable weight, earlier stages (I-II), and younger age. One systematic review assigned tumescent liposuction a Grade 1 recommendation for sustained improvement in symptoms, mobility, and quality of life. A meta-analysis (20 studies, 1785 patients) found liposuction produced large improvements in quality of life (SMD 2.48), pain (SMD 2.04, -72.4%), and pressure sensitivity (SMD 2.20, -68.1%) with low complication rates (seroma 0.82%, infection 0.59%, zero mortality); a further single-arm meta-analysis (6 studies, 429 patients) found tumescent liposuction reduced pooled mean pain from 5.64 to 1.19 in conservative-refractory patients; the LIPLEG RCT cited in one review showed greater early pain reduction and mobility in the surgical group at 6 months. Retrospective before-and-after cohorts and longitudinal studies report durable symptom relief and reduced reliance on conservative therapy (e.g., median ~37.5% reduction in CDT score, ~25.5% discontinuing all conservative therapy), and a survey of 148 surgical patients found 84-90% reporting improved quality of life and willingness to repeat surgery, though complications such as new fibrosis (27.7%), loose skin (75%), and new lipo-lymphedema were noted; higher relative aspirated fat volume and concomitant minor procedures are independent risk factors for postoperative seroma. Surgery is framed as an ADJUNCT within comprehensive care rather than a stand-alone cure—a meta-analysis found ~51% of liposuction patients still require conservative therapy. Guideline positions diverge: the Dutch guidelines and UK NICE 2022 (IPG721, restricting liposuction to research contexts) versus the German S2k guideline (60 formal recommendations) and US 2021 standard of care, with the S2k explicitly recommending against diuretics, supporting bariatric surgery for BMI >=40 (or >=35 with comorbidity), and including manual lymphatic drainage (which the Dutch guideline does NOT recommend). Nutritional therapy including the very-low-calorie ketogenic diet shows preliminary signals of weight loss and transient pain reduction (pain returning to baseline after diet cessation). Psychosocial support and mandatory preoperative psychological assessment before surgery are emphasized. Aside from several systematic reviews graded moderate-to-high, the evidence base remains predominantly low-grade, derived from consensus statements, guidelines, narrative reviews, retrospective cohorts, and small/uncontrolled case series, with a 2022 CADTH review noting zero randomized or controlled comparative trials of liposuction.
A synthesis rendered from the currently indexed evidence — versioned, not a verdict.
⚙ AI consolidation: Claude Opus 4.8 · 2026-07-26 — evidence-bounded; the AI does not opine
This update added a moderate-grade single-arm meta-analysis (6 studies, 429 patients) reinforcing tumescent liposuction's pain reduction, a cohort identifying seroma risk factors, and additional review/exercise context, without altering the overall stepwise conservative-then-surgical recommendation.
Knowledge freshness = share of the 36 indexed evidence sources from the last 5 years (newest 2026, oldest 2006) . Low freshness flags an ageing evidence base — not that the answer is wrong.
Evidence over time
consistent conflicting refining / contextual Each dot is a study, placed by year and coloured by whether the linked claim supports or contradicts the answer. As the surveillance loop runs, claim revisions and new evidence will extend this timeline.
Answer over time
Each node is a published version of the answer — open one to read the answer exactly as it stood then.
Choose a format (Vancouver default). Citing a version captures the evidence state on that date; this page shows the current version — see version history.
Consistent claims
- SCR-LIP-000050 consistent
Conservative management (lifestyle and dietary changes, compression therapy, low-impact exercise) is first-line for lipedema, and surgery (liposuction) should be considered only after an adequate trial of conservative treatment, prioritizing mobility and symptom relief over aesthetic outcomes.
Brazilian Consensus Statement on Lipedema using the Delphi methodology — Amato et al. (2025) · Lipedema: pathophysiological insights and therapeutic strategies – An update for dermatologists — Dal'Forno-Dini et al. (2026) · Lipedema, a Rare Disease — Shin et al. (2025) · S1 guidelines: Lipedema — Reich‐Schupke et al. (2017) · Treatment of lipedema in men — Zubanov & Ignatieva (2025) - SCR-LIP-000049 consistent
Comprehensive management of lipedema requires a multidisciplinary team addressing both physical and mental health.
Brazilian Consensus Statement on Lipedema using the Delphi methodology — Amato et al. (2025) - SCR-LIP-000038 consistent
An individualized, multidisciplinary approach combining conservative anti-inflammatory therapy with staged liposuction (rather than liposuction as a sole cure) is proposed as the optimal treatment model for lipedema.
Efficacy of Liposuction in the Treatment of Lipedema: A Meta-Analysis — Amato et al. (2024) · Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases — Amato & Benitti (2021) - SCR-LIP-000037 consistent
Non-surgical management of lipedema (anti-inflammatory diet, manual lymphatic drainage, aquatic exercise, antioxidant phytotherapeutics) can improve symptoms and reduce limb volume across disease stages in selected patients.
Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases — Amato & Benitti (2021) · Clinical Management of a Patient with Lipo-Lymphedema Using Adjustable Compression Wraps: A Case Report — Alexander et al. (2026) - SCR-LIP-000119 consistent
Complex decongestive therapy (CDT) combined with pneumatic compression applied 6 days/week for 1 month significantly reduced both extracellular (p=0.002) and intracellular (p=0.010) fluid volumes in 22 lipedema patients, suggesting CDT may slow disease progression since extracellular fluid accumulation is considered an accelerating factor.
Can Physical Therapy Techniques Slow Down the Progression of Lipedema? — Esmer & Schingale (2024) - SCR-LIP-000120 consistent
A consensus statement from Italian scientific societies recommends that lipedema management combine physical exercise (aquatic, aerobic, strength training) with complete decongestive therapy (CDT) including manual lymphatic drainage, compression, and dietary interventions, with CDT plus exercise showing superior limb volume reduction compared to intermittent pneumatic compression plus exercise or exercise alone.
The Role of Physical Exercise as a Therapeutic Tool to Improve Lipedema: A Consensus Statement from the Italian Society of Motor and Sports Sciences (Società Italiana di Scienze Motorie e Sportive, SISMeS) and the Italian Society of Phlebology (Società Italiana di Flebologia, SIF) — Annunziata et al. (2024) - SCR-LIP-000121 consistent
Management of lipedema includes weight loss, edema control, complex decongestive physiotherapy, tumescent liposuction, and laser-assisted lipolysis, with tumescent liposuction reported as the preferred surgical option with long-lasting results.
The national cost of hospital‐acquired pressure injuries in the United States — Padula & Delarmente (2019) - SCR-LIP-000163 consistent
This systematic review (1995-2011) reports that lipedema management consists of conservative complex decongestive therapy (CDT) — achieving up to ~10% leg circumference reduction and reduced capillary fragility (13.95 to 8.78 petechiae, P<0.001) — and tumescent liposuction, with early diagnosis and treatment recommended to prevent functional and cosmetic complications, though no clinical guideline or Cochrane recommendation existed as of 2012.
Lipedema: an overview of its clinical manifestations, diagnosis and treatment of the disproportional fatty deposition syndrome – systematic review — Forner‐Cordero et al. (2012) - SCR-LIP-000164 consistent
This narrative review recommends combined conservative therapy (manual or intermittent pneumatic lymphatic drainage, compression bandages and garments, and physiotherapy) with surgical liposuction as a more recent option, plus early recognition, specialized treatment, and regular follow-up to prevent progression.
Lipedema, a hardly known disease: diagnosis, associated illnesses and therapy — Wenczl & Daróczy (2008) - SCR-LIP-000165 consistent
A narrative review proposes the very-low-calorie ketogenic diet (VLCKD) as a nutritional therapy for lipedema, citing anti-inflammatory effects; reported cases include a 6-month ketogenic diet (Cannataro 2021) yielding 41 kg total weight loss, reduced affected-limb circumferences (e.g., arm -10.5 to -11.5 cm), HOMA-IR reduction of 54%, and CRP reduction of 67%, and the LIPODIET trial (n=9) showing -4.5% weight loss and a 50% VAS pain reduction at 7 weeks that returned to baseline after diet cessation, while noting conventional decongestive therapy reduces tissue volume only 5-10%.
Ketogenic Diet: A Nutritional Therapeutic Tool for Lipedema? — Verde et al. (2023) - SCR-LIP-000316 consistent
A systematic review of 61 articles found that conservative therapies (ketogenic/RAD diets, compression, aquatic exercise) reduced pain and swelling (Grade 2A-2B), while tumescent liposuction showed the strongest evidence for sustained symptom improvement, mobility, and quality of life (Grade 1 recommendation), supporting early recognition with combined conservative and surgical management.
Lipedema Diagnosis, Clinical Manifestations, and Therapeutics: A Systematic Review — Vazirnia et al. (2026) - SCR-LIP-000317 consistent
The first Dutch lipedema guidelines, framed by the ICF and Chronic Care Model, recommend a four-pillar conservative management (healthy lifestyle with weight control, graded activity training, flat-knit compression only when edema is present, and psychosocial support; manual lymphatic drainage not recommended) plus tumescent liposuction (TLA/STLA) for abnormal adipose tissue, with structured follow-up and clinical diagnostic criteria.
First Dutch guidelines on lipedema using the international classification of functioning, disability and health — Halk & Damstra (2017) - SCR-LIP-000318 consistent
A systematic review of surgical and non-surgical lipedema treatments concluded that a stepwise, individualized approach is recommended—starting with optimized conservative therapy (compression, exercise, intermittent pneumatic compression) which reduces pain and edema, and progressing to reduction surgery (tumescent, water-assisted, or power-assisted liposuction) in appropriately selected patients, with liposuction showing substantial symptom and quality-of-life improvements and acceptable complication rates.
Liposuction as a Treatment for Lipedema: A Scoping Review — Bejar-Chapa et al. (2025) - SCR-LIP-000320 consistent
The S2k guideline issues 60 formal recommendations advocating multidisciplinary management of lipedema combining conservative measures (compression including MCS flat-knit and intermittent pneumatic compression for pain relief, manual lymphatic drainage, exercise, Mediterranean hypocaloric or ketogenic diet, weight management), psychosocial support, bariatric surgery for BMI >=40 (or >=35 with comorbidity), and liposuction as the surgical method of choice, while explicitly recommending against diuretics.
S2k guideline lipedema — Faerber et al. (2024) - SCR-LIP-000321 consistent
A systematic review of 20 studies (>1200 patients) found that multimodal management of lipedema combining conservative measures (compression, structured exercise, pneumatic compression devices, ketogenic/low-carb diet) and surgical liposuction (tumescent, PAL, WAL) yields significant improvements in pain, mobility, limb circumference and HRQoL; the LIPLEG RCT showed greater early pain reduction and mobility in the surgical group at 6 months, while combined compression plus exercise outperformed exercise alone.
SURGICAL AND NON-SURGICAL APPROACHES IN THE MANAGEMENT OF LIPEDEMA: A SYSTEMATIC REVIEW — Tamura et al. (2025) - SCR-LIP-000322 consistent
A BAAPS/BAPRAS expert consensus recommends managing lipedema with conservative measures and selecting liposuction (tumescent, often staged large-volume) only when symptoms persist >12 months, functional impairment is considerable, weight is stable for 12 months, and BMI is <35 kg/m², performed in a level 2-3 hospital by an experienced surgeon supported by a multidisciplinary team including a lymphedema nurse, with mandatory preoperative psychological assessment and immediate postoperative compression.
Summary document on safety and recommendations on liposuction for lipoedema: Joint British association of aesthetic plastic surgeons (BAAPS)/British association of plastic reconstructive and aesthetic surgeons (BAPRAS) expert liposuction group — Dancey et al. (2022) - SCR-LIP-000247 consistent
In a meta-analysis of 20 studies (1785 patients, mostly tumescent technique), liposuction for lipedema produced significant improvements in quality of life (SMD 2.48), pain (SMD 2.04, 72% reduction), and pressure sensitivity (SMD 2.20), with a low complication profile (seroma 0.82%, hematoma 0.71%, infection 0.59%) and zero mortality over ~15 months follow-up.
Safety and Effectiveness of Liposuction Modalities in Managing Lipedema: Systematic Review and Meta-analysis — Mortada et al. (2024) - SCR-LIP-000326 consistent
In a US survey of 148 women with lipedema who underwent reduction surgery (61% tumescent liposuction, 38% water-assisted), 84% reported improved quality of life, 86% had reduced pain, mobility improved across stages, and 90% would repeat the procedure, though complications including new fibrosis (27.7%), adipose tissue growth in untreated areas, new lipo-lymphedema, and loose skin (75%) were reported.
Survey Outcomes of Lipedema Reduction Surgery in the United States — Herbst et al. (2021) - SCR-LIP-000327 consistent
A practical synthesis chapter describes tumescent liposuction (based on Klein's 1987 technique) as an effective treatment option for symptomatic lipedema refractory to conservative management, with attention to indication, technique, and perioperative care.
Liposuction of Lipedema — Cornely (2006)
Conflicting claims
- None indexed yet.
Refining / contextual
- SCR-LIP-000047 context
Lipedema can negatively impact mental health and quality of life, and delayed diagnosis or late treatment worsens symptom burden and psychological well-being.
Brazilian Consensus Statement on Lipedema using the Delphi methodology — Amato et al. (2025) - SCR-LIP-000162 context
In a 10-year retrospective before-and-after study, lymph-sparing multistage liposuction (median 3 sessions, mean total 17,887 ml aspirated) produced durable improvements, with a median 37.5% reduction in conservative-therapy (CDT) score, 25.5% of patients discontinuing all conservative treatment, and significant VAS symptom reductions; outcomes were better in earlier stages (I+II) and in patients aged <41 years with BMI ≤35 kg/m².
Disease progression and comorbidities in lipedema patients: A 10‐year retrospective analysis — Ghods et al. (2022) · Comparative Analysis of Liposuction and Conservative Treatment in Lipedema Patients: A Modified Body-Q Questionnaire Study — Aitzetmüller-Klietz et al. (2022) · A 10-Year Retrospective before-and-after Study of Lipedema Surgery: Patient-Reported Lipedema-Associated Symptom Improvement after Multistage Liposuction — Kruppa et al. (2022) - SCR-LIP-000319 context
A 2022 CADTH update found zero randomized or controlled comparative trials of liposuction for lipedema and reported divergent guidelines: the UK NICE 2022 (IPG721) restricts liposuction to research contexts due to inadequate efficacy/safety data, while the US 2021 standard of care (Herbst et al.) recommends conservative treatment first and recognizes liposuction as the only technique to remove abnormal lipedema tissue, with both guidelines endorsing specialized multidisciplinary centers.
Liposuction for Lipedema: 2022 Update — Tran & Horton (2022) - SCR-LIP-000324 context
This narrative review synthesizes lipedema treatment modalities including ketogenic diet, exercise, compression, and liposuction alongside its pathophysiology, but does not establish a single recommended overall management protocol.
Lipedema: Progress, Challenges, and the Road Ahead — Cifarelli (2025) · BIESZCZAD, Dominika, BARCZEWSKA, Magdalena, KOWALCZYK, Dominika, REIZER, Barbara, KRYSTEK, Klaudia, FELISIAK, (2026) - SCR-LIP-000252 refines
In a longitudinal study of 25 lipedema patients undergoing tumescent liposuction (mean 3 procedures, mean 9,914 mL removed), spontaneous pain VAS decreased from 7.2 to 4.3, quality-of-life VAS improved from 8.4 to 5.2, and CDT scores fell from 20.5 to 13.9 at ~37 months (all p<0.05), with only 1 erysipelas complication in 72 procedures (1.39%) and better sustained outcomes in stage II than stage III.
Liposuction in the Treatment of Lipedema: A Longitudinal Study — Dadras et al. (2017) - SCR-LIP-000033 refines
In lipedema liposuction, higher relative aspirated fat volume (per 1% body weight) and concomitant minor surgical procedures are independent risk factors for postoperative seroma.
Postoperative Seroma in Lipedema Surgery: A Retrospective Analysis of 93 Cases from a Single Surgical Team — Amato et al. (2026) - SCR-LIP-000415 context
An integrative review sought to identify recommendations for prescribing physical exercise in the management of lipedema, focusing on types and characteristics of interventions.
ISSN 2965-6672 | Qualis A2 (2026) - SCR-LIP-000408 refines
In a single-arm meta-analysis of 6 studies (429 patients), tumescent liposuction reduced pooled mean pain scores from 5.64 preoperatively to 1.19 postoperatively in patients with lipedema refractory to conservative management.
Aesth Plast Surg (2026) 50:1931–1939 (2026)
Major uncertainty
Whether any treatment modifies the disease course (rather than only relieving symptoms) remains undemonstrated, and the surgical evidence base still lacks randomized controlled comparative trials, driving persistent guideline disagreement (notably NICE restricting liposuction to research vs. German/US endorsement).
Version history
- SQ-LIP-000015 · v1.9 — 2026-07-26 — This update added a moderate-grade single-arm meta-analysis (6 studies, 429 patients) reinforcing tumescent liposuction's pain reduction, a cohort identifying seroma risk factors, and additional review/exercise context, without altering the overall stepwise conservative-then-surgical recommendation. · view this version
- SQ-LIP-000015 · v1.8 — 2026-06-02 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000015 · v1.7 — 2026-06-02 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000015 · v1.6 — 2026-06-02 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000015 · v1.5 — 2026-05-31 — This update added multiple systematic reviews (several graded moderate) and national/specialty guidelines (Dutch, German S2k, BAAPS/BAPRAS) plus a larger liposuction meta-analysis and additional cohorts/surveys, strengthening and quantifying the conservative-first, stepwise-with-liposuction model while surfacing key guideline divergences (NICE restricting liposuction to research, conflicting stances on manual lymphatic drainage, recommendation against diuretics) and confirming the absence of randomized controlled liposuction trials. · view this version
- SQ-LIP-000015 · v1.4 — 2026-05-31 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000015 · v1.3 — 2026-05-31 — This update added a 10-year retrospective cohort showing durable benefit and reduced conservative-therapy reliance from lymph-sparing multistage liposuction (better in earlier stages/younger/lower-BMI patients), a moderate-grade systematic review quantifying CDT outcomes, an additional narrative review reinforcing combined conservative-plus-surgical management with follow-up, and a narrative review proposing the VLCKD as a nutritional therapy. · view this version
- SQ-LIP-000015 · v1.2 — 2026-05-31 — This update strengthened the evidence base by adding quantitative CDT outcome data (significant extracellular and intracellular fluid reductions), Italian consensus recommendations explicitly combining CDT with structured exercise programs, German S1 guideline details on Complex Physical Therapy as first-line care, and additional surgical options (laser-assisted lipolysis), providing a more granular and multi-society-endorsed picture of the stepwise management framework. · view this version
- SQ-LIP-000015 · v1.1 — 2026-05-30 — This update added evidence regarding the use of Adjustable Compression Wraps (ACWs) for improving self-care and outcomes in lipo-lymphedema management. · view this version
- SQ-LIP-000015 · v1.0 — 2026-05-30 — founding index (27 claims) · view this version
Key references
DOI:10.1590/1677-5449.202301832 · DOI:10.1016/j.abd.2025.501270 · DOI:10.5535/arm.2011.35.6.922 · DOI:10.1111/ddg.13036 · DOI:10.26779/2786-832x.2025.2.69 · DOI:10.7759/cureus.55260 · DOI:10.12659/AJCR.934406 · DOI:10.26890/dgym6676 · DOI:10.1089/lrb.2024.0065 · DOI:10.1007/s13679-024-00579-8 · DOI:10.1111/iwj.13071 · DOI:10.1111/dth.14534 · DOI:10.3390/jcm14010279 · DOI:10.1097/prs.0000000000008880 · DOI:10.1111/j.1758-8111.2012.00045.x · DOI:10.1556/oh.2008.28490 · DOI:10.1007/s13679-023-00536-x · DOI:10.1111/ijd.70227 · DOI:10.1177/0268355516639421 · DOI:10.1097/gox.0000000000005952 · DOI:10.51731/cjht.2022.413 · DOI:10.1111/ddg.15513 · DOI:10.56238/levv16n53-097 · DOI:10.1016/j.bjps.2022.12.004 · DOI:10.1055/a-2334-9260 · DOI:10.1111/obr.13953 · DOI:10.12775/jehs.2026.87.67421 · DOI:10.5999/aps.2017.44.4.324 · DOI:10.1097/gox.0000000000003553 · DOI:10.1007/3-540-28043-x_86